Dr. Reddy's Laboratories Reports Record Sales Amid Mixed Financial Results in March 2025

Jul 23 2025 06:16 PM IST
share
Share Via
Dr. Reddy's Laboratories announced its financial results for the quarter ending March 2025, showcasing record net sales of Rs 8,528.40 crore and a profit after tax of Rs 1,593.30 crore. Despite these achievements, the company faced challenges, including a decline in profit before tax and concerns over non-operating income sustainability.
Dr. Reddy's Laboratories has recently reported its financial results for the quarter ending March 2025, revealing a mix of positive developments and challenges. The company achieved its highest quarterly net sales at Rs 8,528.40 crore, marking consistent growth over the last five quarters. This upward trend in sales is a notable highlight for the pharmaceutical giant.

Additionally, Dr. Reddy's Laboratories recorded a profit after tax (PAT) of Rs 1,593.30 crore, also the highest in the past five quarters, indicating a positive trajectory in profitability. The earnings per share (EPS) reached Rs 19.10, reflecting the company's ability to generate higher earnings for its shareholders.

However, the financial results also indicate some areas of concern. The profit before tax, excluding other income, stood at Rs 1,483.10 crore, which represents a decline compared to the average of the previous four quarters. Furthermore, while non-operating income reached a peak of Rs 522.10 crore, there are questions regarding the sustainability of this income from non-business activities.

In light of these results, Dr. Reddy's Laboratories has experienced adjustments in its evaluation, reflecting the complexities of its financial landscape.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News